At Rewind Anti-Aging of Miami, we do not prescribe any treatment without discussing its regulatory status, the quality and limitations of available evidence, and how it compares to FDA-approved alternatives
However, as gallbladder disease is not an issue with sodium-glucose co-transporter-2 (SGLT-2) inhibitors (with similar weight loss) (89), and gallbladder events also occurred in GLP-1RA-treated patients well after weight reduction (90), other mechanisms are possibly in play
Sample size calculation The sample size calculation was based on the assumptions of a mean difference in the primary endpoint CDR-SB score of 0.44 points (relating to a 20% difference between semaglutide and placebo when assuming a mean increase in the placebo arm of 2.2 points), standard deviation of 2.6 points, and one-sided significance level of 0.025
MeAgain helps users stay aware without being obsessed by turning the habits that support their bodies, like protein , fiber , hydration , and movement , into a simple, game-like daily flow through the weight-loss tracker app
